With a market cap of $11.2 billion, Align Technology, Inc. (ALGN) develops and provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services to patients and dental professionals worldwide. The company operates through two main segments: Clear Aligners, offering a range of Invisalign products for children, teens, and adults, and Imaging Systems & CAD/CAM Services, providing digital scanning, design software, and orthodontic workflow solutions. The Tempe, Arizona-based com ...

Core Insights - Align Technology, Inc. has a market capitalization of $10.2 billion and is recognized for its Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners, providing advanced orthodontic and restorative digital solutions globally [1] Stock Performance - Over the past 52 weeks, Align Technology's shares have decreased by 37.5%, underperforming the S&P 500 Index, which gained 11% during the same period [2] - Year-to-date, the stock has dropped 31.6%, while the S&P 500 has risen by 12.3% [2] Recent Financial Results - Following the Q3 2025 results released on October 29, shares surged by 4.9%, with adjusted EPS at $2.61 and revenue reaching $995.7 million, surpassing consensus estimates [4] - Align Technology raised its Q4 revenue forecast to between $1.03 billion and $1.05 billion, anticipating mid-single-digit growth in Clear Aligner volumes [4] Earnings Expectations - For the fiscal year ending December 2025, analysts project a 16.7% year-over-year increase in EPS to $8.18 [5] - The company's earnings surprise history is mixed, with two beats and two misses in the last four quarters [5] Analyst Ratings - Among 14 analysts covering Align Technology, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, five "Holds," and one "Moderate Sell" [5] - This rating configuration is slightly less bullish than three months ago, which had nine "Strong Buy" ratings [6] Price Targets - Evercore ISI raised its price target on Align Technology to $170, maintaining an "Outperform" rating [7] - The mean price target of $173.25 indicates a potential upside of 21.5% from the current price, while the highest target of $205 suggests a 43.8% upside [7]